Aliases & Classifications for Vulvitis

MalaCards integrated aliases for Vulvitis:

Name: Vulvitis 12 45 15 17 74

Classifications:



External Ids:

Disease Ontology 12 DOID:3901
MeSH 45 D014847
SNOMED-CT 69 63144007
ICD10 34 N76.2
UMLS 74 C0042996

Summaries for Vulvitis

Disease Ontology : 12 A vulvar disease that is characterized by inflammation of the vulva.

MalaCards based summary : Vulvitis is related to vaginitis and de quervain disease, and has symptoms including pruritus vulvae An important gene associated with Vulvitis is NXN (Nucleoredoxin), and among its related pathways/superpathways is Transcriptional misregulation in cancer. The drugs Acetylcholine and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include testes, colon and skin, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Wikipedia : 77 Vulvitis is inflammation of the vulva, the external female mammalian genitalia that include the labia... more...

Related Diseases for Vulvitis

Diseases related to Vulvitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 55)
# Related Disease Score Top Affiliating Genes
1 vaginitis 10.4
2 de quervain disease 10.4 ELANE MRAP
3 cheilitis 10.3
4 impetigo 10.3 ELANE HSF4
5 aortitis 10.3 MPO MRAP
6 cerebral aneurysms 10.3 ELANE MPO
7 pasteurellosis 10.3 ELANE MPO
8 balanitis 10.3
9 rapidly progressive glomerulonephritis 10.3 ELANE MPO
10 vulval paget's disease 10.3 KRT7 LINC01191
11 capillary leak syndrome 10.3 CSF2 ELANE
12 aleukemic leukemia cutis 10.3 ELANE MPO
13 vulvar disease 10.3 KRT7 LINC01191
14 vulva adenocarcinoma 10.3 KRT7 LINC01191
15 penile disease 10.3 LINC01191 MRAP
16 crohn's disease 10.3
17 herpes simplex 10.3
18 marek disease 10.2 GYPC TNFRSF8
19 cyclic neutropenia 10.2 CSF2 ELANE
20 anterior scleritis 10.2 MPO MRAP
21 granulocytopenia 10.2 CSF2 MPO
22 bronchopneumonia 10.2 ELANE HSF4 MPO
23 intratubular embryonal carcinoma 10.2 KRT7 TNFRSF8
24 pericardium cancer 10.2 KRT7 MPO
25 melkersson-rosenthal syndrome 10.2
26 malignant leydig cell tumor 10.2 KRT7 TNFRSF8
27 pulmonary hemosiderosis 10.2 KRT7 MPO
28 hodgkin's lymphoma, lymphocytic depletion 10.2 CSF2 TNFRSF8
29 thymus lipoma 10.1 KRT7 TNFRSF8
30 respiratory system disease 10.1 CSF2 ELANE MPO
31 immune system organ benign neoplasm 10.1 KRT7 TNFRSF8
32 endometritis 10.1
33 squamous cell carcinoma 10.1
34 lichen sclerosus 10.1
35 vulva cancer 10.1 KRT7 LINC01191
36 pericardial mesothelioma 10.1 KRT7 MPO
37 suppurative lymphadenitis 10.0 DECR1 HSF4
38 ecthyma 10.0 CSF2 TNFRSF8
39 trichosporonosis 10.0 CSF2 DECR1
40 lichen sclerosus et atrophicus 10.0
41 epidermodysplasia verruciformis 1 10.0
42 crohn's colitis 10.0
43 postmenopausal atrophic vaginitis 10.0
44 interstitial cystitis 10.0
45 cystitis 10.0
46 vulvovaginitis 10.0
47 dermatitis 10.0
48 purpura 10.0
49 salpingitis 10.0
50 leukoplakia 10.0

Graphical network of the top 20 diseases related to Vulvitis:



Diseases related to Vulvitis

Symptoms & Phenotypes for Vulvitis

UMLS symptoms related to Vulvitis:


pruritus vulvae

GenomeRNAi Phenotypes related to Vulvitis according to GeneCards Suite gene sharing:

27 (show all 16)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-11 9.58 TNFRSF8
2 Increased shRNA abundance (Z-score > 2) GR00366-A-116 9.58 DECR1
3 Increased shRNA abundance (Z-score > 2) GR00366-A-128 9.58 DECR1
4 Increased shRNA abundance (Z-score > 2) GR00366-A-137 9.58 TNFRSF8
5 Increased shRNA abundance (Z-score > 2) GR00366-A-138 9.58 CSF2
6 Increased shRNA abundance (Z-score > 2) GR00366-A-151 9.58 DECR1
7 Increased shRNA abundance (Z-score > 2) GR00366-A-16 9.58 TNFRSF8
8 Increased shRNA abundance (Z-score > 2) GR00366-A-168 9.58 DECR1
9 Increased shRNA abundance (Z-score > 2) GR00366-A-170 9.58 CSF2
10 Increased shRNA abundance (Z-score > 2) GR00366-A-190 9.58 CSF2
11 Increased shRNA abundance (Z-score > 2) GR00366-A-210 9.58 CSF2
12 Increased shRNA abundance (Z-score > 2) GR00366-A-214 9.58 DECR1
13 Increased shRNA abundance (Z-score > 2) GR00366-A-4 9.58 TNFRSF8
14 Increased shRNA abundance (Z-score > 2) GR00366-A-5 9.58 TNFRSF8
15 Increased shRNA abundance (Z-score > 2) GR00366-A-67 9.58 CSF2 DECR1 TNFRSF8
16 Increased shRNA abundance (Z-score > 2) GR00366-A-85 9.58 DECR1

Drugs & Therapeutics for Vulvitis

Drugs for Vulvitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 109)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acetylcholine Approved, Investigational Phase 4,Phase 3 51-84-3 187
2
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22916-47-8 4189
3
Fluconazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 86386-73-4 3365
4
Clotrimazole Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 23593-75-1 2812
5
Dequalinium Approved, Investigational Phase 4 6707-58-0
6
Terconazole Approved Phase 4,Phase 3,Not Applicable 67915-31-5 441383
7
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Phase 1,Not Applicable 137-58-6 3676
8
Petrolatum Approved, Investigational Phase 4,Phase 2 8009-03-8
9
Tamoxifen Approved Phase 4 10540-29-1 2733526
10
Tinidazole Approved, Investigational Phase 4 19387-91-8 5479
11 abobotulinumtoxinA Phase 4,Phase 3
12 Acetylcholine Release Inhibitors Phase 4,Phase 3
13 Botulinum Toxins Phase 4,Phase 3
14 Cholinergic Agents Phase 4,Phase 3
15 Botulinum Toxins, Type A Phase 4,Phase 3
16 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Not Applicable
17 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
18 Steroid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
19 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
20 Cytochrome P-450 CYP2C9 Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
21 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
22 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
23 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
24 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
25 Cytochrome P-450 CYP2C19 Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
26 Anti-Infective Agents, Local Phase 4,Phase 3
27 Cytochrome P-450 CYP3A Inhibitors Phase 4,Phase 3,Not Applicable
28 Estrogen Receptor Antagonists Phase 4
29 Aromatase Inhibitors Phase 4
30 Estrogens Phase 4,Phase 2
31 Tea Phase 4
32 Estrogen Antagonists Phase 4
33 Tomato Approved Phase 3
34
Nifedipine Approved Phase 3 21829-25-4 4485
35
Norepinephrine Approved Phase 3 51-41-2 439260
36
Levomilnacipran Approved, Investigational Phase 3 96847-54-0
37
Milnacipran Approved, Investigational Phase 3 92623-85-3 65833
38
Clindamycin Approved, Vet_approved Phase 3,Not Applicable 18323-44-9 29029
39
Butoconazole Approved Phase 3,Not Applicable 64872-76-0, 64872-77-1 47472
40
Ketoconazole Approved, Investigational Phase 3 65277-42-1 47576
41
Tetracycline Approved, Vet_approved Phase 3 60-54-8 5353990
42
Amphotericin B Approved, Investigational Phase 3,Phase 2 1397-89-3 5280965 14956
43
Capsaicin Approved Phase 2, Phase 3,Phase 1 404-86-4 1548943
44
Calcium Approved, Nutraceutical Phase 3,Phase 2 7440-70-2 271
45 Calcium, Dietary Phase 3,Phase 2
46 Vasodilator Agents Phase 3
47 Tocolytic Agents Phase 3
48 calcium channel blockers Phase 3,Phase 2
49 Psychotropic Drugs Phase 3,Phase 2,Not Applicable
50 Antidepressive Agents Phase 3,Phase 2,Not Applicable

Interventional clinical trials:

(show top 50) (show all 94)
# Name Status NCT ID Phase Drugs
1 Botox on Vulvar Vestibulitis Unknown status NCT00119886 Phase 4 Botulinum toxin
2 Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis Completed NCT02248506 Phase 4
3 Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis Completed NCT02242695 Phase 4 Fluomizin vaginal tablets;Canesten vaginal tablets
4 Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis Completed NCT02180828 Phase 4 Clotrimazole vaginal tablet;Fluconazole
5 Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis Completed NCT02180100 Phase 4 Terconazole Vaginal Suppository;Fluconazole
6 Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina Completed NCT00194324 Phase 4 Miconazole nitrate
7 Topical Treatment for Sexual Pain, Vulvar Pain, in Postmenopausal Women Not Taking Estrogens or Similiar Hormones. Women on Aromatase Inhibitors or Tamoxifen CAN Enter the Clinical Trial Recruiting NCT03682601 Phase 4 Sinecatechins Topical
8 Evaluation of Efficacy and Safety of Gynomax® XL Ovule Not yet recruiting NCT03839875 Phase 4 Gynomax® XL Vaginal Ovule
9 Dysbiosis in Localized Provoked Vulvodynia (LPV) Unknown status NCT02393911 Phase 3
10 Efficacy Study of Topical Application of Nifedipine Cream to Treat Vulvar Vestibulitis Completed NCT00496184 Phase 3 Nifedipine cream topical application
11 Savella in Treatment for Provoked Vestibulodynia Completed NCT01304589 Phase 3 Milnacipran
12 Vaginal Infection Study Completed NCT00616330 Phase 3 clindamycin phosphate/butoconazole nitrate;clindamycin phosphate;butoconazole nitrate
13 ProF-001_Phase IIa Completed NCT03115073 Phase 2, Phase 3 Candiplus;Clotrimazole
14 Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis Completed NCT02251093 Phase 3 Lcr Regenerans;Placebo
15 The Study Of Fluconazole For Vulvovaginal Candidiasis Completed NCT01806623 Phase 3 Fluconazole
16 A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077) Completed NCT01293643 Phase 3 100 mg clindamycin /800 mg ketoconazole vaginal ovule;100 mg tetracycline hydrochloride /50 mg amphotericin B cream
17 Comparative Efficacy of Ovule vs Tablet Completed NCT00755053 Phase 3 Clotrimazole, vaginal ovule;Clotrimazole, vaginal tablet
18 Diabetes Mellitus and Vulvovaginal Candidiasis Completed NCT00353561 Phase 3 Boric;Fluconazole
19 A Pilot Study of the Effects of Botulinum Toxin in the Treatment of Provoked Vestibulodynia Recruiting NCT02858219 Phase 3 Botulinum Toxin Type A
20 A Study of the Effects of Topical Capsaicin in the Treatment of Provoked Vestibulodynia Recruiting NCT02854670 Phase 2, Phase 3 Capsaicin patch
21 Placebo-controlled RCT of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia Recruiting NCT02773641 Phase 3 Botulinum Toxin Type A;Sterile Saline Solution
22 Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Cream. Recruiting NCT03005353 Phase 2, Phase 3 Cumin seed extract;clotrimazole
23 Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis Recruiting NCT03734991 Phase 3 Ibrexafungerp;Placebo
24 A Study of Oral VT-1161 for the Treatment of Acute Vaginal Candidiasis (Yeast Infection) in Patients With Recurrent Vaginal Candidiasis Recruiting NCT03840616 Phase 3 VT-1161 150 mg capsule;Fluconazole 150 mg
25 A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) Recruiting NCT03562156 Phase 3 VT-1161;Placebo
26 A Study of Oral VT-1161 for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) Recruiting NCT03561701 Phase 3 VT-1161;Placebo
27 Ketoconazole Gel Versus Terconazole Cream for Vaginal Candidiasis Not yet recruiting NCT03473418 Phase 3 Ketoconazole;Terconazole
28 Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis Withdrawn NCT02907307 Phase 3 Clotrimazole vaginal tablet 100mg
29 Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis Completed NCT00004316 Phase 1, Phase 2 capsaicin
30 Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) Completed NCT02971007 Phase 2 Oral Encochleated Amphotericin B (CAMB);Fluconazole
31 RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections Completed NCT02733432 Phase 2 CD101 Vaginal Gel (3%);CD101 External gel (1%);CD101 Vaginal Ointment (6%);CD101 External ointment (1%);Fluconazole
32 An Active-Controlled, Dose-Finding Study of SCY-078 vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis Completed NCT03253094 Phase 2 Fluconazole;SCY-078
33 TOL-463 Phase 2 Study for Vaginitis Completed NCT02866227 Phase 2 TOL-463;TOL-463
34 Safety and Efficacy of Oral SCY-078 vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis Completed NCT02679456 Phase 2 SCY-078;Fluconazole
35 A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) Completed NCT02267382 Phase 2 VT-1161;Placebo
36 Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis Completed NCT01926028 Phase 1, Phase 2
37 A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection) Completed NCT01891331 Phase 2 VT-1161;Fluconazole
38 MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis Completed NCT01497223 Phase 2 MGCD290
39 Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment Completed NCT01144286 Phase 2 arasertaconazole nitrate;placebo
40 Patients With Vulvovaginal Candidiasis Recruiting NCT03024502 Phase 1, Phase 2 EPP-AF Gel 1%;EPP-AF Gel 2%;Clotrimazole
41 Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments Not yet recruiting NCT03844412 Phase 2 5% lidocaine/5 mg/ml estradiol compound cream;Nortriptyline;Placebo cream;Placebo pill
42 5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis Terminated NCT00450242 Phase 2 5% topical lidocaine ointment;Placebo cream
43 Pregabalin for the Treatment of Vulvodynia Terminated NCT00853229 Phase 2 pregabalin
44 Efficacy Vulvovaginitis Candida Terminated NCT00199264 Phase 2 Albaconazole oral solution
45 Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis Withdrawn NCT03167957 Phase 2 Oral Encochleated Amphotericin B (CAMB);Oral Encochleated Amphotericin B (CAMB)
46 Use of Oral Probiotics as an Adjunctive Therapy to Fluconazole in the Treatment of Yeast Vaginitis Unknown status NCT00479947 Phase 1 Probiotics (Natural product);Probiotics (L. rhamnosus GR-1 and L. reuteri RC-14)
47 Provoked, Localized Vulvodynia Treatment With Acupuncture and Lidocaine Pilot Study Completed NCT01996384 Phase 1 Lidocaine
48 Study Evaluating the Optimal Dosage for Equivalence Between Lcr Regenerans® Capsules and Tablets (Lactobacillus Rhamnosus Lcr35®) on the Vaginal Flora Colonisation Completed NCT02730494 Phase 1
49 Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection Completed NCT01067131 Phase 1
50 Physiotherapy Intervention for Provoked Vulvar Vestibulodynia Unknown status NCT01628679 Not Applicable

Search NIH Clinical Center for Vulvitis

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: vulvitis

Genetic Tests for Vulvitis

Anatomical Context for Vulvitis

MalaCards organs/tissues related to Vulvitis:

42
Testes, Colon, Skin, Thymus

Publications for Vulvitis

Articles related to Vulvitis:

(show top 50) (show all 138)
# Title Authors Year
1
Hypertrophic Herpes Simplex With Subsequent Development of Plasma Cell Vulvitis: A Potential Diagnostic Pitfall. ( 30870250 )
2019
2
Mucinous Metaplasia of the Vulva in Zoon Vulvitis and Lichen Sclerosus et Atrophicus. Description of 3 Additional Cases of a Rarely Reported Histopathologic Finding. ( 30252696 )
2019
3
Plasma cell vulvitis presenting as postmenopausal atrophic vaginitis - a case report. ( 31018733 )
2019
4
Idiopathic granulomatous vulvitis and subsequent oral granulomatosis: a diagnostic and therapeutic challenge. ( 30221373 )
2019
5
A vexing vulvitis: a case report and review of plasma cell vulvitis. ( 31006288 )
2019
6
Candidal vulvitis: a possible trigger for lichen striatus. ( 29888701 )
2018
7
Plasma cell vulvitis: further confirmation of the diagnostic utility of dermoscopy. ( 30229875 )
2018
8
Zoon vulvitis - a rare form of chronic inflammation of the vulva. ( 30441960 )
2018
9
Evaluation of safety and skin tolerability of organic cotton pads in case of irritative vulvitis. ( 30465412 )
2018
10
Successful treatment of intractable vulvitis circumscripta plasmacellularis via combination therapy with topical tacrolimus and tetracycline. ( 27786391 )
2017
11
Zoon Vulvitis Treated Successfully With Platelet-Rich Plasma: First Case Reported. ( 28857965 )
2017
12
Zoon vulvitis. ( 29267481 )
2017
13
Case 4: Vulvitis in a nonsexually active adolescent girl. ( 26941554 )
2016
14
Comparative study on topical immunomodulatory and anti-inflammatory treatments for plasma cell vulvitis: long-term efficacy and safety. ( 25059818 )
2015
15
Symptoms in plasma cell vulvitis: first observational cohort study on type, frequency and severity. ( 25633048 )
2015
16
Plasma cell vulvitis. ( 26692614 )
2015
17
Granulomatous cheilitis with granulomatous vulvitis: a rare association. ( 24177613 )
2013
18
Zoon vulvitis as a differential diagnosis in an HIV-infected patient: a short report. ( 23449712 )
2013
19
Longstanding Crohn's vulvitis successfully treated with combined anti-TNFα antibody and azathioprine. ( 23815219 )
2013
20
Vulvitis granulomatosa, Melkersson-Rosenthal syndrome, and Crohn's disease: dramatic response to infliximab therapy. ( 22788815 )
2012
21
Plasma cell vulvitis: a vulvar itching dilemma. ( 22421677 )
2012
22
Asymptomatic granulomatous vulvitis and granulomatous cheilitis in childhood: the need for Crohn disease workup. ( 21694543 )
2011
23
Diagnosis and treatment of Zoon's vulvitis. ( 21823840 )
2011
24
Clinical effectiveness of a special silk textile in the treatment of recurrent pediatric inflammatory vulvitis: an open label pilot study. ( 21956267 )
2011
25
Vulvitis plasmacellularis circumscripta in pre-existing lichen sclerosus: treatment with imiquimod 5% cream. ( 20542167 )
2010
26
Case series of Zoon vulvitis. ( 20040837 )
2010
27
Zoon's vulvitis (vulvitis circumscripta plasmacellularis). ( 20333391 )
2010
28
Chronic vulvitis in pre-pubertal girls. ( 20546218 )
2010
29
Idiopathic pustular vulvitis. ( 19778311 )
2009
30
Ulcerative vulvitis and balanitis in sheep flocks. ( 18641377 )
2008
31
Tacrolimus 0.1% ointment: is it really effective in plasma cell vulvitis? Report of four cases. ( 18182819 )
2008
32
'HPV vulvitis' revisited: frequent and persistent detection of novel epidermodysplasia verruciformis-associated HPV genotypes. ( 18251739 )
2008
33
A case of idiopathic granulomatous cheilitis and vulvitis. ( 17614801 )
2007
34
Extensive mucinous metaplasia of the vulva arising within Zoon's vulvitis. ( 17263821 )
2007
35
Contact vulvitis due to Pseudowintera Colorata in a topical herbal medicament. ( 17340033 )
2007
36
Successful treatment of Zoon's vulvitis with high potency topical steroid. ( 15834511 )
2006
37
Vulvitis circumscripta plasmacellularis: success with a modified treatment regimen using imiquimod. ( 16390720 )
2006
38
Imiquimod treatment of vulvitis circumscripta plasmacellularis. ( 16777111 )
2006
39
Ulcerative balanitis and vulvitis of Dorper sheep in South Africa: a study on its aetiology and clinical features. ( 16642715 )
2005
40
In vitro antimicrobial susceptibility of Mycoplasma mycoides mycoides large colony and Arcanobacterium pyogenes isolated from clinical cases of ulcerative balanitis and vulvitis in Dorper sheep in South Africa. ( 16642716 )
2005
41
Retrospective histopathologic reevaluation of 18 cases of plasma cell vulvitis. ( 15730165 )
2005
42
Plasma cell vulvitis: a rare cause of intractable vulvar pruritus. ( 15967935 )
2005
43
Topical misoprostol therapy for plasma cell vulvitis: a case series. ( 16044059 )
2005
44
Apareunia in a patient with Zoon's vulvitis. ( 16147756 )
2005
45
A case of vulvitis granulomatosa. ( 16361737 )
2005
46
Ulcerative vulvitis circumscripta plasmacellularis. ( 14986474 )
2004
47
Are patch tests useful in plasma cell vulvitis? ( 15018438 )
2004
48
Idiopathic granulomatous vulvitis. ( 15250899 )
2004
49
Vulvitis granulomatosa and unilateral hypertrophy of the vulva related to Crohn's disease: a case report. ( 15547549 )
2004
50
Squamous cell carcinoma of the bladder presenting as vulvitis and cliteromegaly. ( 15581990 )
2004

Variations for Vulvitis

Expression for Vulvitis

Search GEO for disease gene expression data for Vulvitis.

Pathways for Vulvitis

Pathways related to Vulvitis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.07 CSF2 ELANE MPO

GO Terms for Vulvitis

Biological processes related to Vulvitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 defense response to fungus GO:0050832 9.16 ELANE MPO
2 negative regulation of growth of symbiont in host GO:0044130 8.96 ELANE MPO
3 response to yeast GO:0001878 8.62 ELANE MPO

Sources for Vulvitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....